We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04614194
Recruitment Status : Recruiting
First Posted : November 3, 2020
Last Update Posted : October 4, 2022
Eli Lilly and Company
Cancer Prevention Research Institute of Texas
Information provided by (Responsible Party):
Sangeetha Reddy, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 22, 2023
Estimated Study Completion Date : December 22, 2024